DISCLAIMER: GOLDINVESTMENTCOMPANIES.COM IS AN AFFILIATED PARTNER FOR GOLDCO PRECIOUS METALS, AUGUSTA PRECIOUS METALS, AND BIRCH GOLD GROUP, PROMOTING THEIR GOLD IRA, GOLD 401K TRANSFER AND BITCOIN IRA SERVICES AND PRODUCTS.
Description: David Regan, CEO of Sona Nanotech, discusses innovations in nanotechnology applications in medicine, and how the company’s proprietary gold nanorods can potentially help with cancer therapies.
00:38 Overview of Sona Nanotech
01:19 Nanotech application in medicine
04:30 Sona Nanotech’s Targeted Hyperthermia Therapy (THT)
07:45 Focus on colorectal cancer
09:38 Preclinical study for THT
10:55 Why invest in nanotechnology and Sona Nanotech
13:33 Challenges in nanotechnology adoption in medicine
#nanotechnology #investing #nanotechstocks
Investing News Network (INN)
Find out more about investing by INN @
Browse our 2023 outlook reports:
Follow us Facebook:
Follow us on Twitter:
The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.